Lung Cancer: Basic and Clinical Aspects

[1]  I. Stratford.  Mechanisms of hypoxic cell radiosensitization and the development of new sensitizers. , 1982, International journal of radiation oncology, biology, physics.

[2]  G Gamsu,et al.  Computed Tomography of the Abnormal Pulmonary Hilum , 1981, Journal of computer assisted tomography.

[3]  Clift,et al.  Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. , 1976, Blood.

[4]  D. Gandara,et al.  Upper abdominal CT scanning in staging non-oat-cell lung carcinoma. , 1982, The New England journal of medicine.

[5]  T. Phillips,et al.  Radiation therapy oncology group clinical trials with misonidazole , 1981, Cancer.

[6]  H. Hansen,et al.  Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung. , 1984, Cancer treatment reports.

[7]  R. Wittes,et al.  Role of radiation therapy in small cell anaplastic carcinoma of the lung. , 1983, Cancer treatment reports.

[8]  K E Stanley,et al.  Prognostic factors for survival in patients with inoperable lung cancer. , 1980, Journal of the National Cancer Institute.

[9]  S. Dische,et al.  Primary tumor control after radiotherapy for carcinoma of the bronchus. , 1984, International journal of radiation oncology, biology, physics.

[10]  T. Phillips,et al.  Large fraction radiotherapy plus misonidazole for treatment of advanced lung cancer: report of a phase I/II trial. , 1980, International journal of radiation oncology, biology, physics.

[11]  H. Hansen,et al.  Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small-cell lung cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  K. Drzewiecki,et al.  Survival with malignant melanoma: A regression analysis of prognostic factors , 1982, Cancer.

[13]  G. Bydder,et al.  Nuclear magnetic resonance imaging of the posterior fossa: 50 cases. , 1983, Clinical radiology.

[14]  F. Hirsch,et al.  Peritoneoscopy in the staging of 190 patients with small‐cell anaplastic carcinoma of the lung with special reference to subtyping , 1978, Cancer.

[15]  W. Evans,et al.  Computed Tomography of the Brain, Liver, and Upper Abdomen in the Staging of Small Cell Carcinoma of the Lung , 1982, Journal of computer assisted tomography.

[16]  F. Muggia,et al.  Irradiated lung cancer. An autopsy analysis of spread pattern. , 1975, Radiology.

[17]  P. Postmus,et al.  High-Dose Chemotherapy for Small Cell Lung Cancer , 1986 .

[18]  P. Friedman.  Computed tomography in lung cancer. , 1982, American journal of surgery.

[19]  D. Osoba,et al.  VP‐16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer , 1984, Cancer.

[20]  P. Workman,et al.  Chemosensitization by lipophilic nitroimidazoles. , 1983, British Journal of Cancer.

[21]  V. Ferrans,et al.  ACUTE LETHAL CARDITIS CAUSED BY HIGH-DOSE COMBINATION CHEMOTHERAPY A Unique Clinical and Pathological Entity , 1976, The Lancet.

[22]  P. Neiman,et al.  High‐dose cyclophosphamide therapy for malignant disease. Toxicity, tumor response, and the effects of stored autologous marrow , 1972 .

[23]  J. Lundar.  Small-celled anaplastic lung carcinoma. Patients alive five years after operation. , 1970, Scandinavian journal of respiratory diseases. Supplementum.

[24]  H. Bush,et al.  Clinical trial of razoxane and radiotherapy for inoperable carcinoma of the bronchus. , 1979, International journal of radiation oncology, biology, physics.

[25]  H. Nakagawa,et al.  Computed tomography and radionuclide brain scanning: comparison in evaluating metastatic lesions to brain. , 1980, New York state journal of medicine.

[26]  H. Hansen,et al.  Cyclic alternating 'non-cross resistant' chemotherapy in the management of small cell anaplastic carcinoma of the lung. , 1984, Cancer Treatment Reviews.

[27]  H. Hansen,et al.  Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop. , 1983, Cancer treatment reports.

[28]  R. Simon.  Importance of prognostic factors in cancer clinical trials. , 1984, Cancer treatment reports.

[29]  D. Siemann,et al.  Potentiation of chemotherapy by hypoxic cell radiation sensitizers--a review. , 1982, International journal of radiation oncology, biology, physics.

[30]  P. Sørensen,et al.  Cerebrospinal fluid vasopressin as a marker of central nervous system metastases from small-cell bronchogenic carcinoma. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  G. Simonetti,et al.  TNM staging in lung cancer: role of computed tomography. , 1982, The Journal of thoracic and cardiovascular surgery.

[32]  M. Peckham,et al.  The combination of 5-fluorouracil with misonidazole in patients with advanced colorectal cancer. , 1982, International journal of radiation oncology, biology, physics.

[33]  J. Gottdiener,et al.  Cardiotoxicity associated with high-dose cyclophosphamide therapy. , 1981, Archives of internal medicine.

[34]  M. Oster,et al.  Meningeal carcinomatosis in small cell carcinoma of the lung. , 1982, Medical and pediatric oncology.

[35]  A. Wang,et al.  Spinal cord or nerve root compression in patients with malignant disease: CT evaluation. , 1984, Journal of computer assisted tomography.

[36]  R. Guttmann.  Experiences in the treatment of inoperable carcinoma of the lung with 2 mV. and cobalt 60 irradiation. , 1958, The American journal of roentgenology, radium therapy, and nuclear medicine.

[37]  A. Rauth,et al.  Pharmacology and toxicology of sensitizers: mechanism studies. , 1984, International journal of radiation oncology, biology, physics.

[38]  L. White.  Serum enzymes. II. Glycolytic enzymes in patients with cancer and other diseases. , 1958, Journal of the National Cancer Institute.

[39]  I. Smith,et al.  The viability of marrow stored at 4oC , 1984 .

[40]  N. Bleehen,et al.  A phase I study of the combination of benznidazole and CCNU in man. , 1984, International journal of radiation oncology, biology, physics.

[41]  R. Weiss,et al.  The nitrosoureas and pulmonary toxicity. , 1981, Cancer treatment reviews.

[42]  R. Souhami,et al.  Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. , 1984, British medical journal.

[43]  F. Hirsch,et al.  Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lung. , 1983, Cancer research.

[44]  J. Posner,et al.  Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. , 1974, Archives of neurology.

[45]  J. Posner,et al.  Intramedullary spinal cord metastases , 1972, Neurology.

[46]  H. Goldstein,et al.  Comparison of scintigraphy, sonography, and computed tomography in the evaluation of hepatic neoplasms. , 1979, AJR. American journal of roentgenology.

[47]  D. Ettinger,et al.  Staging and prognostic factors in small cell carcinoma of the lung. , 1983, Cancer treatment reports.

[48]  B. Sikic,et al.  Diagnostic accuracies of clinical studies in patients with small cell carcinoma of the lung. , 1983, Journal of Clinical Oncology.

[49]  R. Hooper,et al.  Computed tomographic scanning of the brain in initial staging of bronchogenic carcinoma. , 1984, Chest.

[50]  R. Makuch,et al.  Diagnosis and significance of liver metastases in small cell carcinoma of the lung. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  C. Jameson,et al.  Stevens-Johnson syndrome associated with etoposide therapy. , 1983, Cancer treatment reports.

[52]  G. Favez,et al.  POSTERIOR OBLIQUE TOMOGRAPHY AT AN ANGLE OF 55° IN CHEST ROENTGENOLOGY , 1974 .

[53]  J. Minna,et al.  CNS metastases in small cell bronchogenic carcinoma. Increasing frequency and changing pattern with lengthening survival , 1979, Cancer.

[54]  W. Fry,et al.  Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure. , 1981, The Annals of thoracic surgery.

[55]  J. Bitran,et al.  Sequential scintigraphic staging of small cell carcinoma , 1981, Cancer.

[56]  T. Phillips,et al.  Promise of radiosensitizers and radioprotectors in the treatment of human cancer. , 1984, Cancer treatment reports.

[57]  P. Workman,et al.  Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU. , 1982, British Journal of Cancer.

[58]  R. Murphy,et al.  Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans. , 1983, British Journal of Cancer.

[59]  R. M. Peters,et al.  Multiorgan scans for staging lung cancer. Correlation with clinical evaluation. , 1977, The Journal of thoracic and cardiovascular surgery.

[60]  C. Putman,et al.  Comparison of plain radiography, conventional tomography, and computed tomography in detecting intrathoracic lymph node metastases from lung carcinoma. , 1982, Radiology.

[61]  G. Green,et al.  Mitomycin‐C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second‐line regimen in lung cancer , 1984, American journal of clinical oncology.

[62]  J. Pagani.  Non‐small cell lung carcinoma adrenal metastases computed tomography and percutaneous needle biopsy in their diagnosis , 1984, Cancer.

[63]  S. Seeber,et al.  Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin. , 1984, Cancer treatment reports.

[64]  A. Elbadawi,et al.  Long-term survivorship in small-cell anaplastic lung carcinoma. , 1979, Cancer treatment reports.

[65]  A. Goldhirsch,et al.  Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung. , 1982, Cancer treatment reports.

[66]  K J Rothman,et al.  Epidemiologic methods in clinical trials , 1977, Cancer.

[67]  C. Coleman,et al.  Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward? , 1984, International journal of radiation oncology, biology, physics.

[68]  R. Urtasun,et al.  Pharmacokinetic interaction of BCNU and misonidazole in humans. , 1982, International journal of radiation oncology, biology, physics.

[69]  M. Cohen.  Is immediate radiation therapy indicated for patients with unresectable non-small cell lung cancer? No. , 1983, Cancer treatment reports.

[70]  C D Buckner,et al.  Marrow transplantation for acute lymphoblastic leukemia. , 1984, Seminars in hematology.

[71]  S. Dische,et al.  Clinical experience with nitroimidazoles as radiosensitizers. , 1982, International journal of radiation oncology, biology, physics.

[72]  H. Hansen,et al.  Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma. , 1981, Cancer treatment reports.

[73]  L. H. Gray,et al.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.

[74]  M. Korobkin,et al.  Preoperative CT evaluation of adrenal glands in non-small cell bronchogenic carcinoma. , 1982, AJR. American journal of roentgenology.

[75]  M. Zelen.  Strategy and alternate randomized designs in cancer clinical trials. , 1982, Cancer treatment reports.

[76]  H. Hansen,et al.  Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung a double‐blind randomized trial , 2006, Cancer.

[77]  J. Posner,et al.  Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients , 1982, Cancer.

[78]  D. V. Van Echo,et al.  Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations. , 1982, Cancer treatment reports.

[79]  D. Ettinger,et al.  Phase III study of CCNU, cyclophosphamide, adriamycin, vincristine, and VP‐16 in small‐cell carcinoma of the lung , 1982, Cancer.

[80]  T. Pajak,et al.  Prognostic factors in small cell carcinoma of the lung: a cancer and leukemia group B study. , 1981, Cancer treatment reports.

[81]  L. H. Gray,et al.  The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.

[82]  A. Zander,et al.  Early pulmonary toxicity after administration of high-dose BCNU. , 1981, Cancer treatment reports.

[83]  E. Gattavecchia,et al.  Clinical trials with cyclophosphamide and misonidazole combination for maintaining treatment after radiation therapy of lung carcinoma. , 1984, International journal of radiation oncology, biology, physics.

[84]  P. Ruotsalainen,et al.  Misonidazole and radiotherapy in lung cancer: a randomized double-blind trial. , 1982, International journal of radiation oncology, biology, physics.

[85]  T. Pajak,et al.  A randomized combined modality trial in small cell carcinoma of the lung comparison of combination chemotherapy‐radiation therapy versus cyclophosphamide‐radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation , 1980, Cancer.

[86]  P. Goldstraw,et al.  Preoperative staging of lung cancer: accuracy of computed tomography versus mediastinoscopy. , 1983, Thorax.

[87]  G. Atassi.  Do we need new chemosensitive experimental models? , 1984, European journal of cancer & clinical oncology.

[88]  I. Smith,et al.  High-dose cyclophosphamide (7 g/m2) with or without autologous bone marrow rescue after conventional chemotherapy in the treatment of patients with small cell lung cancer. , 1983, Cancer treatment reviews.

[89]  P. Ganz,et al.  Karnofsky performance status revisited: reliability, validity, and guidelines. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[90]  F. Hirsch,et al.  Prophylactic irradiation in bronchogenic small cell anaplastic carcinoma. A comparative trial of localized versus extensive radiotherapy including prophylactic brain irradiation in patients receiving combination chemotherapy , 1980, Cancer.

[91]  P. Sadler,et al.  Hypoxic cell sensitization to radiation damage by a new radiosensitizer: cis-dichloro-bis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole-N3)platinum(II) (flap). , 1982, British Journal of Cancer.

[92]  E. Gehan,et al.  Prediction of remission in adult acute leukemia. Development and testing of predictive models , 1982, Cancer.

[93]  C. Putman,et al.  Distinguishing benign from malignant pulmonary nodules by computed tomography. , 1982, Radiology.

[94]  Skipper He,et al.  Tumor stem cell heterogeneity: implications with respect to classification of cancers by chemotherapeutic effect. , 1984 .

[95]  Posner Jb.  Management of central nervous system metastases. , 1977, Seminars in oncology.

[96]  J. Cox,et al.  Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation. , 1981, Cancer treatment reports.

[97]  J. Hainsworth,et al.  High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[98]  R Storb,et al.  Technique for human marrow grafting. , 1970, Blood.

[99]  E. de Vries,et al.  Cyclophosphamide and VP 16-213 with autologous bone marrow transplantation. A dose escalation study. , 1984, European journal of cancer & clinical oncology.

[100]  B. Madrazo,et al.  Computed tomographic evaluation of the adrenal gland in the preoperative assessment of bronchogenic carcinoma. , 1982, Radiology.

[101]  F. Hirsch,et al.  Intracranial metastases in small cell carcinoma of the lung prognostic aspects , 1983, Cancer.

[102]  D. V. Van Echo,et al.  CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma. , 1982, Cancer treatment reports.

[103]  R. Simon,et al.  Randomized clinical trials and research strategy. , 1982, Cancer treatment reports.

[104]  E. Langvad.  Lactate dehydrogenase isoenzymes in cancer , 1972 .

[105]  P. Kvale,et al.  The value of radiographic and computed tomography in the staging of lung carcinoma. , 1983, The Annals of thoracic surgery.

[106]  H. Brereton,et al.  Spinal meningeal carcinomatosis in small-cell carcinoma of the lung. , 1978, Annals of internal medicine.

[107]  T. Phillips,et al.  Prospective randomized trial of large fraction radiotherapy and misonidazol in advanced non-oat cell lung cancer , 1984 .

[108]  S. Dische,et al.  A controlled clinical trial of misonidazole in the radiotherapy of patients with carcinoma of the bronchus. , 1982, International journal of radiation oncology, biology, physics.

[109]  I. Cade,et al.  Clinical trials of radiotherapy in hyperbaric oxygen at Portsmouth, 1964--1976. , 1978, Clinical radiology.

[110]  O S Miettinen,et al.  Stratification by a multivariate confounder score. , 1976, American journal of epidemiology.

[111]  J H Goldie,et al.  Rationale for the use of alternating non-cross-resistant chemotherapy. , 1982, Cancer treatment reports.

[112]  F. Hirsch,et al.  Metastatic patterns in small-cell lung cancer: correlation of autopsy findings with clinical parameters in 537 patients. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[113]  R. Makuch,et al.  Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. , 1981, The American review of respiratory disease.

[114]  Goldie Jh,et al.  Quantitative model for multiple levels of drug resistance in clinical tumors. , 1983 .

[115]  F. Hirsch,et al.  Chemotherapy of advanced small-cell anaplastic carcinoma. Superiority of a four-drug combination to a three-drug combination. , 1978, Annals of internal medicine.

[116]  G. Clamon,et al.  Radiotherapy plus razoxane for advanced limited extent carcinoma of the lung , 1984, Cancer.

[117]  J. Rubin,et al.  ICRF-159 versus polychemotherapy in non-small cell lung cancer. , 1976, Cancer treatment reports.

[118]  R. Livingston,et al.  Isolated pleural effusion in small cell lung carcinoma: favorable prognosis. A review of the Southwest Oncology Group experience. , 1982, Chest.

[119]  N. J. McNally,et al.  Enhancement of chemotherapy agents. , 1982, International journal of radiation oncology, biology, physics.

[120]  S. Spiro.  Chemotherapy for small cell lung cancer. , 1985, British medical journal.

[121]  T. Kinsella,et al.  The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizers. , 1984, International journal of radiation oncology, biology, physics.

[122]  F. Hirsch,et al.  Bone marrow involvement in small cell anaplastic carcinoma of the lung. Prognostic and therapeutic aspects , 1980, Cancer.

[123]  G Gamsu,et al.  Computed Tomography of the Normal Pulmonary Hilum , 1981, Journal of computer assisted tomography.

[124]  P. Rissanen,et al.  Autopsy analysis of the effective radiation dose sterilizing bronchial carcinoma. , 1980 .

[125]  R. Aur,et al.  Cyclophosphamide‐induced hemorrhagic cystitis in children with leukemia , 1975, Cancer.

[126]  D.,et al.  Regression Models and Life-Tables , 2022 .

[127]  O. Kokron,et al.  Ifosfamid versus Ifosfamid + CCNU in der Behandlung des inoperablen kleinzelligen Bronchuskarzinoms , 1982 .

[128]  R. Simon,et al.  Patient subsets and variation in therapeutic efficacy. , 1982, British journal of clinical pharmacology.

[129]  H. Hansen,et al.  Etoposide (VP-16) in the treatment of lung cancer. , 1983, Cancer treatment reviews.